The FDA-approved system is designed for providing moderate sedation to patients undergoing select gastrointestinal procedures, such as screening colonoscopy or EGD.
“It really allows us to use propofol, which we believe is superior to midazolam and fentanyl, in outpatients without having the added cost of having anesthesiologists administer [the drug],” said gastroenterologist Otto Lin, MD, according to the report.
More articles on gastroenterology:
The biggest threats to success in the GI field
9 GI physicians earning honors
6 GI physicians in the news
